The James and Esther King Biomedical Research Program funds research targeting cancer, cardiovascular, stroke, and pulmonary diseases in Florida, with special emphasis on tobacco-related conditions.
Funder: Florida James and Esther King Biomedical Research Program
Due Dates: September 2, 2026 (Letter of Intent) | October 21, 2026 (Full application)
Funding Amounts: Up to $1,500,000 total for most categories (36–48 months); equipment and bridge grants up to $100,000 (12 or 6 months).
Summary: Supports biomedical research to improve prevention, diagnosis, and treatment of cancer, cardiovascular disease, stroke, and pulmonary disease in Floridians, with emphasis on tobacco-related conditions.
Key Information: Only Florida-based universities and established research institutes are eligible; all activities and funds must be spent in Florida.
The James and Esther King Biomedical Research Program provides competitive grant funding to support research that addresses major health challenges in Florida, focusing on cancer, cardiovascular disease, stroke, and pulmonary disease—particularly those linked to tobacco use. The program aims to improve prevention, diagnosis, treatment, and cures for these diseases, expand biomedical knowledge, integrate research advances into health professional training, and stimulate Florida’s biomedical sector. Projects must demonstrate clear relevance to tobacco-related diseases and their impact on Floridians.